Healthcare Professionals - Learn About Transdermal Verapamil 15% Gel For Fibrotic Tissue Disorders

Transdermal Verapamil 15% Gel Clinical Data

Click on the titles below to review a study.

Peyronie's Disease

57 Patient Double-blind placebo-controlled study - This 4 armed study compared PDLabs' Transdermal Verapamil 15% Gel to two other drugs and placebo to determine efficacy and safety of the medication.

645 Patient Study - This open-label study evaluated the efficacy and safety of PDLabs' Transdermal Verapamil 8% Gel

214 Patient Study - This open-label study evaluated the efficacy and safety of PDLabs' Transdermal Verapamil 8% Gel

Skin Penetration Study - A study demonstrating the ability of PDLabs' Transdermal Verapamil 15% Gel to successfully penetrate to the tunica albuginea.

Plantar Fibromatosis

In-progress efficacy and safety study - This is an open label study using objective metrics to determine the efficacy and safety of Transdermal Verapamil 15 % Gel.

Dupuytren's Disease

There are currently no studies available for Dupuytren's disease.